Cam Gallagher, Director at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 19,477 shares at $44.90 ($875K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Open-market sale of $875k ZNTL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.90 | 9,477 | $426K | 48.6% |
| 2 | $44.90 | 9,477 | $426K | 48.6% |
| 3 | $45.56 | 523 | $24K | 2.7% |
| Total | $44.92 avg | 19,477 | $875K | 100% |
| Filing → |
| ZNTL | SELL | 2024-02-12 | $13K | — | Filing → |
| ZNTL | SELL | 2024-02-05 | $267K | — | Filing → |
| ZNTL | SELL | 2023-05-31 | $1.5M | — | Filing → |